If you are taking a treatment for the symptoms of osteoarthritis, check the serial numbers of these.
The Pierre Fabre Médicament laboratory recalls "lots G20078 and G20079 of the drug Structum 500 mg, capsule (box of 60 - expiry date 11/2024)", said the National Medicines Safety Agency in a press release this Friday.
This recall follows the identification of a risk of bacterial contamination of the drug during quality control, specifies the French drug authority (ANSM).
Pharmacists are invited to quickly contact the patients concerned to inform them as soon as possible.
What if you have already taken medication from this batch?
Available with or without a prescription, Structum 500 mg in the form of capsules is indicated for patients over 15 years of age in the event of osteoarthritis of a hip or knee.
The batches concerned have been available in pharmacies since January 2022.
In the event of ingestion of a contaminated capsule, the patient may experience diarrhea or gastrointestinal disturbances, and even nausea and vomiting.
In immunocompromised patients, the risk of possible bacterial dissemination – which can lead to serious adverse effects such as meningitis or endocarditis – cannot be ruled out, warns the ANSM.
The latter must therefore consult a doctor if they have taken capsules from the boxes concerned.
Health
Brioche Pasquier containing foreign bodies recalled
Company
Casino recalls salads due to presence of banned pesticide
Health
Medication
Recall
Regional Health Agency